UroGen Pharma
URGN
$10.54
Share price
-5.89%
Change (1 day)
-25.20%
Change (1 year)
Categories
UroGen Pharma (URGN) - Cash on Hand
Cash on Hand as of December 2024 : $0.23 Billion USD
According to UroGen Pharma's latest financial reports the company has $0.23 Billion USD in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
UroGen Pharma - Cash on Hand chart (from 2016 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | $0.23 B | 72.8% |
| 2023-12-31 | $0.13 B | 37.02% |
| 2022-12-31 | $99.96 M | 12.14% |
| 2021-12-31 | $89.13 M | -12.62% |
| 2020-12-31 | $0.10 B | -30.64% |
| 2019-12-31 | $0.14 B | 45.16% |
| 2018-12-31 | $0.10 B | 38.79% |
| 2017-12-31 | $73 M | 241.73% |
| 2016-12-31 | $21.36 M | 18.84% |
| 2015-12-31 | $17.97 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | $0.25 B | 8.14% | 🇺🇸 USA |